Dileucine and Resistance Training Adaptations (NCT06121869) | Clinical Trial Compass
CompletedNot Applicable
Dileucine and Resistance Training Adaptations
United States34 participantsStarted 2021-05-07
Plain-language summary
This study seeks to compare the observed changes in resistance training adaptations after supplementation of isomolar amounts of leucine or dileucine in healthy resistance-trained men. This will provide a better understanding of supplementation with leucine versus dileucine over a 10-week period in regards to increasing muscular performance.
Who can participate
Age range18 Years – 39 Years
SexMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male
* Between the ages of 18-39 years of age
* Currently participating in resistance training exercise
Exclusion Criteria:
* Female
* Participants who are determined to not be weight stable defined as week 0 and week 2 body mass levels deviating by 3% or more.
* Any individual who is currently being treated for or diagnosed with a cardiac, respiratory, circulatory, musculoskeletal, metabolic, immune, autoimmune, psychiatric, hematological, neurological or endocrinological disorder or disease.
* Body mass index \> 25 kg/m2. Individuals with a body mass index greater than 25 kg/m2, but a body fat percentage less than 25% fat will be accepted into the study
* Individuals who present with any previous injury or illness that would prevent them from appropriately completing all exercise lifts.
* Participants who are not able to fit onto the DEXA table will not be able to participate in the research due to size restrictions of the equipment. This typically includes individuals exceeding 400 pounds or those greater than 6'4".
* Those individuals with less than 12 months of structured resistance training experience will be excluded from the study.
* Individuals whose maximal relative upper body strength is below 1.0 will be excluded.
* Individuals whose maximal relative lower body strength is below 1.5 will be excluded.
* All participants who DO NOT abstain from taking any additional forms of nutritional supplementation deemed to be ergogenic or that will imp…